Cancer Research UK completes £280m buy-in with Standard Life

Life sciences, research, healthcare

Cancer Research UK has insured around 2,800 members of its defined benefit pension scheme through a bulk annuity deal, which covers more than half of its liabilities.

Register now for FREE to read this article

If you are already a registered you can SIGN IN now

Register today for free!

It’s quick and easy, and as a registered user you’ll have full access to all Pension Expert articles. You will also be able to recieve editorial emails.

  • Full access to all news, analysis and expert comment
  • The latest industry insights delivered to your inbox on a Tuesday and Thursday morning
  • The Friday Takeaway newsletter reviewing the major events of the week
  • Bookmark your favourite articles for easy review
  • Hear about and register to attend Pensions Expert and DG Publishing events